%0 Journal Article
%T Trial of canakinumab, an IL-1¦Â receptor antagonist, in patients with inclusion body myositis
%A Athanasios G. Tzioufas
%A Dimitris Pikazis
%A Marinos C. Dalakas
%A Michalis L. Kosmidis
%A Panayotis Vlachoyiannopoulos
%J Archive of "Neurology£¿ Neuroimmunology & Neuroinflammation".
%D 2019
%R 10.1212/NXI.0000000000000581
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624107/